J. Broséus, J. Park, and S. Carillo, Presence of calreticulin mutations in JAK2-negative polycythemia vera, Blood, vol.124, issue.26, pp.3964-3966, 2014.
DOI : 10.1182/blood-2014-06-583161

S. E. Langabeer, K. Haslam, and C. M. Flynn, Isolated erythrocytosis associated with a CALR mutation, Blood Cells, Molecules, and Diseases, vol.66, 2017.
DOI : 10.1016/j.bcmd.2017.07.001

I. Chachoua, C. Pecquet, and M. El-khoury, Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, vol.127, issue.10, 2015.
DOI : 10.1182/blood-2015-11-681932
URL : http://www.bloodjournal.org/content/bloodjournal/127/10/1325.full.pdf

A. Chauveau, O. Nibourel, and S. Tondeur, -negative polycythemia, Haematologica, vol.102, issue.1, pp.15-16, 2017.
DOI : 10.3324/haematol.2016.154799

A. Spolverini, L. Pieri, and P. Guglielmelli, Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis, Haematologica, vol.98, issue.9, pp.101-102, 2013.
DOI : 10.3324/haematol.2013.090175

L. Velazquez, -deficient Mice, The Journal of Experimental Medicine, vol.81, issue.12, pp.1599-1611, 2002.
DOI : 10.1038/ng0796-309

N. Maslah, B. Cassinat, and E. Verger, The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders, Leukemia, vol.7, issue.8, pp.1661-1670, 2017.
DOI : 10.18632/oncotarget.11773

C. Orvain, D. Paz, and I. Dobo, Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study, Annals of Hematology, vol.30, issue.11, pp.1819-1823, 2016.
DOI : 10.1038/leu.2015.277
URL : https://hal.archives-ouvertes.fr/inserm-01382431